Embryos can be exposed to environmental factors that induce hypoxia. Currently, our understanding of the effects of hypoxia on early mammalian development is modest. Potential mediators of hypoxia action include the nucleoside adenosine, which acts through A 1 adenosine receptors (A1ARs) and mediates adverse effects of hypoxia on the neonatal brain. We hypothesized that A 1ARs may also play a role in mediating effects of hypoxia on the embryo. When pregnant dams were exposed to hypoxia (10% O2) beginning at embryonic day (E) 7.5 or 8.5 and continued for 24 -96 h, A 1AR؉/؉ embryos manifested growth inhibition and a disproportionate reduction in heart size, including thinner ventricular walls. Yet, when dams were exposed to hypoxia, embryos lacking A 1ARs (A1AR؊/؊) had much more severe growth retardation than A 1AR؉/؉ or ؉/؊ embryos. When levels of hypoxia-inducible factor 1␣ (HIF1␣) were examined, A1AR؊/؊ embryos had less stabilized HIF1␣ protein than A1AR؉/؊ littermates. Normal patterns of cardiac gene expression were also disturbed in A1AR؊/؊ embryos exposed to hypoxia. These results show that short periods of hypoxia during early embryogenesis can result in intrauterine growth retardation. We identify adenosine and A1ARs as playing an essential role in protecting the embryo from hypoxia.
D
eveloping embryos can be exposed to a number of environmental insults, including those that induce hypoxia (1) . Fetal hypoxia occurs in pregnant women who live at high altitude and women who smoke during pregnancy (1) (2) (3) . Anemia, placental insufficiency, cord compression, preeclampsia, and heart, lung, and kidney disease can cause hypoxemic states in the fetus, as well (1) .
Available evidence suggests that hypoxia can affect developing fetuses. Exposing chick embryos to hypoxia over the first 3.5 days of embryo development causes general growth inhibition and altered cardiovascular function (4) . Hypoxia is an important part of normal mammalian cardiac development because local tissue hypoxia drives shortening and rotation of the outflow track (5) . Fetal hypoxia is also associated with intrauterine growth retardation and reduced birth weight (1, 6, 7) .
At present, our understanding of the factors that mediate the effects of hypoxia on the developing fetus is limited. Given the roles of adenosine in many biological processes (8) , it may play an important role in fetal hypoxia. Adenosine levels are low under basal conditions but increase Ͼ100-fold with hypoxia (9) . Specific G protein-coupled receptors transduce the biological effects of adenosine (10) . These receptors include A1 adenosine receptors (A 1 ARs), which are activated with modest elevations in adenosine levels (10) .
A 1 ARs are expressed in the developing heart as soon as the myocardium becomes apparent at embryonic stages, and prenatal A 1 AR expression is largely restricted to the heart and the brain (11) . Embryonic cardiac A 1 AR expression appears to be driven by the transcription factors GATA4 and Nkx2.5, which are expressed in the heart during early embryogenesis (12) . As soon as the heart begins to beat, A 1 ARs regulate embryonic heart rate, and adenosine is the dominant prenatal humoral regulator of the fetal heart rate (13) . Increased activation of A 1 AR leads to reduced heart rates in embryonic hearts (13) . Activation of A 1 ARs in embryos has also been observed to reduce myocyte proliferation (14) . As the fetus matures, A 1 AR expression becomes greater in the atria than the ventricles, and A 1 AR expression persists in the heart throughout adulthood (11) .
A 1 ARs do not appear to be essential for normal fetal development. A 1 AR-deficient (Ϫ/Ϫ) mice do not have birth defects, nor are they growth-retarded (15) . In the postnatal period, A 1 ARs transduce the adverse effects of hypoxia on the developing brain (16) . Activation of A 1 ARs over the first 2 postnatal weeks leads to white-matter injury in rodents (16) . In contrast, deletion of A 1 ARs or chemical blockade of A 1 ARs protects the newborn from hypoxia-induced white-matter injury (16, 17) . A 1 AR signaling has also been shown to protect cells from damage. Deletion of adenosine deaminase leads to elevated adenosine levels and protects the heart from ischemic/ reperfusion injury (18, 19) . Overexpression of A 1 AR also helps to protect the heart from ischemic/reperfusion injury and conversely the loss of A 1 AR impairs ischemic tolerance (18, 19) . In addition, adenosine signaling through the A 2a receptor has shown to be protective under hypoxic conditions in the lung by inhibiting the immune response (8) .
Another important mediator of hypoxia action is hypoxiainducible factor-1␣ (HIF1␣) (20) . HIF1␣ stabilization is induced by a series of hypoxia-triggered cellular biochemical events (21) . HIF1␣ binds to hypoxia-response elements in the promoter region of a number of genes to alter gene expression (22) . HIF1␣-deficient (Ϫ/Ϫ) mice have defective cardiovascular development, demonstrating an essential role for this protein in embryogenesis (23) . HIF1␣ expression is regulated by adenosine in cell-based systems through A 3 AR (24) . Yet, it is not known whether adenosine or A 1 AR activation plays a role in HIF1␣ stabilization in vivo (25) .
Based on the above observations, we postulated that adenosine acting through A 1 ARs may influence the developing embryo and possibly transduce the adverse effects of hypoxia on the developing mammalian embryo. We now report that hypoxia impairs cardiac development and leads to intrauterine growth retardation. Most importantly, we find that A 1 ARs play a critical role in protecting the embryo from hypoxia, identifying the adenosinergic system as a critical element in embryo protection.
Results
To examine effects of hypoxia on the developing embryo, pregnant dams were exposed to 10% oxygen. This concentration of O 2 is predicted to give a P O 2 level in the dam of between 25 and 30 mmHg (1 mmHg ϭ 133 Pa) (26). To verify that this condition induced embryonic hypoxia, we used Hypoxyprobe-1, which forms conjugates when tissue O 2 levels are Ͻ10 mmHg (27) .
Dams were housed in hypoxia (10% O 2 , n ϭ 3) or room air from embryonic day (E)7.5 through E10.5 (n ϭ 3). Analysis of tissue sections demonstrated that 10% oxygen induced Hypoxyprobe-1 labeling throughout the developing embryo (Fig.  1B) . In contrast, labeling was not seen in embryos of room air-exposed dams (Fig. 1 A) .
After confirming that 10% O 2 induced embryonic hypoxia, pregnant dams (E7.5) were placed in 10% O 2 or room air for 72 h. Compared with normoxic embryos (Fig. 1C) , we observed a modest degree of growth retardation in hypoxic embryos ( Fig.  1D ) with a reduction of 24% in the crown-rump (C-R) lengths (normoxia, n ϭ 5; hypoxia, n ϭ 8; t test P Ͻ 0.0001). Further examination of hypoxic hearts revealed that some had an enlarged pericardium that was filled with blood, indicating possible heart failure (Fig. 1D) . The length of the left ventricles (LVs), from the boundary with the atrioventricular (AV) canal to the apex of heart, was reduced by 35% in the hypoxia-treated embryos (Fig. 1G) . The width (right-left axis) of the LVs was 12% less, but the width of the right ventricles (RVs) was reduced by 40% in the hypoxic embryos (Fig. 1G) . The RV length was reduced by 29% by hypoxia treatment (Fig. 1G) . Of note, several of the heart measurements, including RV length, RV width, and LV length showed a greater reduction in size than was observed in the whole embryo (P Յ 0.05, two-way ANOVA).
In addition to a reduction in chamber size, hypoxia exposure resulted in thinner ventricular walls (Fig. 2) . In two sets of experiments, embryos were exposed to hypoxic conditions in utero for 48 h. In the first set, embryos were rendered hypoxic from E7.5 to E9.5, collected on E9.5, and examined histologically. In the other set, embryos were exposed to hypoxia from E8.5 to E10.5 and allowed to recover for 24 h in room air before collection at E11.5. In both studies, hypoxia-exposed embryos had reduced heart wall thickness ( Fig. 2 C and D) compared with normoxic controls (Fig. 2 A and B) . Immunohistochemistry revealed conjugates, which form at Ͻ10 mmHg, throughout the tissues in hypoxia-exposed embryos (B) but not in normoxia controls (A). Hypoxic embryos and hearts (D and F) were considerably smaller than room air control embryos and hearts (C and E). (G) The length (from AV canal boundary to the apex of heart) and width of the RV and LV were all significantly smaller in the hypoxia-treated hearts. In some cases the reduction is significantly more than that seen in the embryo overall (24%), including a 35% reduction in the LV length and a 40% decrease in the width of the RV.
Normoxia, n ϭ 5; hypoxia, n ϭ 8. * , P Յ 0.01; ** , P Յ 0.0001 (t test). At, atrium; Hypoxia causes a reduction in myocardial tissue. Dams were exposed to hypoxia from E7.5 to E9.5. Hearts from mice exposed to hypoxia (C) had thinner LV walls compared with normoxia controls (A). (E) This decrease in tissue was quantitated by measuring the cross-sectional area of the ventricular myocardium and AV canal cushions. Hypoxia exposure caused a 43% loss of myocardial tissue and a 21% decrease in cushion area. n ϭ 4 per treatment. (B and D) Dams were exposed to hypoxia from E8.5 to E10.5 followed by 1 day in room air. (F) In hypoxic hearts, ventricular myocardium was reduced 46%, and AV canal cushions were reduced 40%; however, the area of the OFT cushions was not affected. * , P Յ 0.0001 (t test). (Scale bars: 100 m.)
To quantitate the reduction in cardiac tissue, the crosssectional areas of the ventricular myocardium and AV canal cushions were determined. We observed a reduction in ventricular myocardial area of 42% and a reduction in AV canal cushion tissue of 21% in embryos exposed to hypoxia from E7.5 to E9.5 ( Fig. 2E ). In addition to the slight decrease in AV cushion tissue, there was a major decrease in the number of transformed mesenchyme in the AV canal cushions ( Fig. 2 A and C, arrows). Normoxia embryos had 7.21 cells per 100 m 2 (n ϭ 4) of cushion tissue compared with 2.19 cells per 100 m 2 (n ϭ 4) in the hypoxic embryos, which represents a 70% decrease in mesenchymal cell formation (Student's t test, P Ͻ 6.3 ϫ 10 Ϫ11 ). For the slightly older embryos, we observed a reduction in myocardium of 46%, and the AV canal cushions area was down 40%, but no significant effects on the OFT cushion size were observed (Fig. 2F) .
We next examined whether increased cell death or reduced cell proliferation was the cause of reduced ventricle thicknesses. Dams with E9.5 embryos were exposed to hypoxia or room air for 24 h, and embryos were then examined for cell death. In the normoxic embryos, there was sporadic staining of dead cells and a cluster of TUNEL-positive cells in the head mesenchyme and very few labeled cells in the developing heart [supporting information (SI) Fig. 6 ]. After 24 h of hypoxia, TUNEL staining was similar to that observed in control embryos (SI Fig. 6 ).
Immunostaining for phosphohistone H3 was performed on embryo sections from normoxic and hypoxic embryos by comparing the number of H3-positive cells with the total number of cells that were counterstained with propidium iodide. The proliferation rate in the myocardium under normoxic conditions was 1.21% (SEM ϭ 0.14, n ϭ 3), and the proliferation rate under hypoxia was 0.57% (SEM ϭ 0.08, n ϭ 3), indicating a 53% decrease in proliferation rates with 24 h of hypoxia exposure (t test, P Ͻ 0.01).
Embryos were exposed to hypoxic conditions in vitro to determine whether the effects of hypoxia represent direct effects on the developing embryo or indirect effects mediated by influences of hypoxia on the dam. Exposing embryos to hypoxia for 12 h from E8.5 to E9.0 resulted in an array of malformations. These findings include failure of the head folds to fuse, failure of the tail to turn to the ventral side, and dilation of the hearts (SI Fig. 7) .
Long-term effects of early hypoxia exposure on fetal and cardiac development were examined. Dams were exposed to hypoxia for 48 h from E8.5 to E10.5 and allowed to recover in room air until embryos were collected at E18.5. The hearts of fetuses exposed to hypoxia were smaller than normoxic control hearts (Fig. 3) . The length of the LV (mitral valve to the apex of the heart) was reduced by 16% with hypoxia treatment (Fig. 3C) . The width of the ventricles was reduced by 10%, and the thickness of the LV wall was reduced by 31% (Fig. 3C) . No significant effects on the size of the atria (data not shown) or the thickness of the RV wall were observed (Fig. 3C) .
We next assessed the role of A 1 ARs in mediating the effects of intrauterine hypoxia. Timed-pregnant dams from A 1 ARϩ/Ϫ ϫ A 1 ARϪ/Ϫ matings were exposed to hypoxia or room air from E8.5 to E12.5. Embryo sizes were determined by measuring the C-R length. Under normoxic conditions, A 1 ARϪ/Ϫ embryos were indistinguishable from A 1 ARϩ/ϩ or ϩ/Ϫ embryos in size or structure (Table 1 , P Յ 0.01, ANOVA). Under hypoxic conditions, A 1 ARϩ/Ϫ embryos manifested mild growth retardation compared with normoxic A 1 ARϩ/Ϫ (Fig. 4) , but they were indistinguishable from hypoxic A 1 ARϩ/ϩ pups (Table 1) . In comparison, A 1 ARϪ/Ϫ hypoxic embryos had very hypoplastic hearts and severe growth retardation compared with hypoxic A 1 ARϩ/Ϫ embryos from the same litters (Fig. 4 and Table 1 ).
There was a 3-fold increase in the percentage of embryos that were severely growth retarded, which was defined as a size Ͻ50% of A 1 ARϩ/ϩ normoxia embryo size (Fig. 4J) . After hypoxia exposure, 45% of A 1 ARϪ/Ϫ embryos were severely growthretarded compared with 14% of the A 1 ARϩ/Ϫ and 15% of A 1 ARϩ/ϩ embryos (Fig. 4J) . We observed reduced survivability of A 1 ARϪ/Ϫ embryos as well. After 4 days of hypoxia (E8.5-E12.5), 50% of embryos from A 1 ARϪ/Ϫ litters were reabsorbed, compared with 7% of embryos from A 1 ARϩ/ϩ litters (Fig. 4I) .
HIF1␣ plays an important role in mediating responses to hypoxia (28) and may be regulated by adenosine (29) . To address whether HIF1␣ plays a role in hypoxia and A 1 AR action, we examined HIF1␣ protein levels during hypoxic conditions. E10.5 pregnant dams were exposed to hypoxia or room air for 6 h. Because of the small size of embryonic hearts at this age, protein expression was examined in whole embryos. Under hypoxic conditions, HIF1␣ protein was stabilized and accumulated in A 1 ARϩ/Ϫ specimens. Yet, in the A 1 ARϪ/Ϫ embryos, the amount of stabilized HIF1␣ protein was Ͻ50% A 1 ARϩ/Ϫ embryos of the same litter averaged over three experiments (P Ͻ 0.05; Early hypoxic exposure leads to decreased heart size at E18.5. Dams were exposed to hypoxia from E8.5 to E10.5 followed by room air until E18.5. Hypoxia-exposed embryos (B) had smaller hearts than normoxia controls (A). Hypoxia can also induce changes in gene expression, some of which are mediated by HIF1␣ and others that are independent of HIF (30, 31) . To examine changes in cardiac gene expression in response to hypoxia, real-time PCR (quantitative PCR) was used to assess changes in Hand1, Hand2, Nkx2.5, MEF2c, and GATA4 gene expression. Embryos were exposed to hypoxic conditions in utero for 24 h from E9.5 to E10.5. These genes were selected because they play critical roles in heart development (32). We found that Hand1, which is critical for LV development (33), was down-regulated 2.5-fold (0.5 SEM, n ϭ 4) by hypoxic exposure. Cardiac expression of GATA4 (n ϭ 3), Nkx2.5 (n ϭ 3), MEF2c (n ϭ 3), and Hand2 (n ϭ 3) was not altered by 24 h of hypoxia treatment in A 1 ARϩ/ϩ embryos.
To understand further whether hypoxia and altered A 1 AR signaling lead to altered cardiac gene expression, we examined an array of hypoxia-responsive genes by using a real-time PCR-based array system. The mouse hypoxia signaling pathway array contains 84 genes from many different gene groups, including response to stress, signal transduction, protein metabolism, cell growth, and transcription factors (34) (35) (36) (37) . Several genes that are typically protective against hypoxia, including adrenomedullin (ADM), carbonic anhydrase 1 (CAR1), and catalase (38-40), were up-regulated in hypoxia-exposed A 1 ARϩ/ϩ hearts; however, these genes were not up-regulated in A 1 ARϪ/Ϫ hearts (SI Table 2 ).
Discussion
Studying mice during embryogenesis, we find that hypoxia during critical periods of heart formation inhibits ventricular development and results in intrauterine growth retardation. Our data also show that A 1 ARs play a critical role in protecting the embryo against the prenatal effects of hypoxia.
In our studies, we chose a system validated to induce hypoxia in rodents (16) . Supporting the effectiveness of the hypoxia chamber system, we demonstrated that exposing pregnant dams to 10% oxygen induced hypoxia in developing embryos. Exposure of A 1 ARϩ/ϩ embryos to hypoxia resulted in embryos that were growth-retarded, without gross abnormalities. The hearts of these embryos were disproportionately small, with enlarged pericardia. Hypoxia also caused a significant reduction in the thickness of the ventricular myocardium, which was not the result of increased apoptosis. Rather, we observed altered H3 labeling, indicating reduced cell division.
In conjunction with the decrease in LV size, we observed a decrease in cardiac Hand1 gene expression after hypoxia exposure. Decreased Hand1 expression in transgenic models leads to LV hypoplasia, like that seen in the hypoxia-exposed embryos (16), we examined the effects of hypoxia treatment on A 1 ARϪ/Ϫ embryos. Our observations support the notion that A 1 AR signaling is not critical for normal development (15) , yet A 1 ARs are extremely important for embryo protection during hypoxia exposure. Hypoxia-exposed A 1 ARϪ/Ϫ embryos had increased embryonic death. In the surviving embryos, loss of A 1 ARs caused profound growth retardation and reduced cardiac tissue. Because A 1 AR expression is detectable only in the heart at the ages we are studying (11), it is likely that A 1 ARs in the heart are the key site of A 1 AR action. In future studies using models in which A 1 ARs are selectively deleted from the heart, it should be possible to test this notion.
We also observed that loss of A 1 ARs reduced the amount of stabilized HIF1␣ protein in whole embryos in response to hypoxia. Because of the amount of protein present in embryonic hearts, it was not practical to assess HIF1␣ stabilization in isolated hearts. Yet, in whole embryos we observed reduced HIF1␣ stabilization. Because of the critical role that HIF1␣ plays in mediating cellular responses to hypoxia, reduced HIF1␣ stabilization in A 1 ARϪ/Ϫ embryos exposed to hypoxia, altered HIF1␣ action may be a critical factor in fetal growth retardation.
Another interesting finding in the A 1 ARϪ/Ϫ embryos exposed to hypoxia was the altered patterns of hypoxia-responsive gene expression. Several genes that are typically protective against hypoxia were up-regulated in hypoxia-exposed A 1 ARϩ/ϩ hearts; however, these genes were not up-regulated in A 1 ARϪ/Ϫ hearts (SI Table 2 ). We also observed a number of genes that were down-regulated both in A 1 ARϩ/ϩ and A 1 ARϪ/Ϫ embryos, including transcription factor (Dr1) and retinoic acid receptor ␣ (RAR␣). These findings indicate that there are specific molecular cascades affected by altered adenosine signaling. It also appears that genes regulated by HIF1␣ in response to hypoxia are more affected by the loss of A 1 AR activity than are genes regulated independently of HIF1␣. Several of the genes that had altered expression in A 1 ARϩ/ϩ hearts in response to hypoxia, but not in A 1 ARϪ/Ϫ hearts [ADM, CAR1, and peroxisome proliferator-activated receptor ␣ (PPAR␣)], are directly regulated by HIF1␣ activity (30, 31, 34) .
Overall, we identify adenosine and A 1 ARs as critical protectors of the embryo exposed to hypoxia. We show that hypoxia during embryogenesis can result in growth retardation. This observation has important clinical implications because many environmental-and disease-related effects can lead to hypoxic conditions in the developing fetus.
Materials and Methods
Animals. All experiments conducted on animals in this work were first approved by the Institutional Animal Care and Use Committee (IACUC) of Yale University. A 1 ARϩ/ϩ C57BL/6 mice (Charles River Laboratories, Wilmington, MA) and A 1 ARdeficient mice (A 1 ARϪ/Ϫ) were studied (15) . Timed matings were used to obtain the appropriate stage embryos, with E0.5 designating the day a vaginal plug was observed.
Genomic DNA was isolated from tail biopsies or embryonic yolk sacs with the DNeasy tissue kit from Qiagen (Valencia, CA). To genotype A 1 AR animals, PCR was performed as described previously (16) .
For all in utero hypoxia studies, dams were placed in a Plexiglas chamber (Biospherix, Redfield, NY) equipped with an oxygen sensor that maintains ambient O 2 levels between 9.5 and 10.5% by introducing 100% medical grade nitrogen into the chamber (16) . This level of oxygen was selected because pregnant dams tolerate this concentration (41) , and adverse effects on embryogenesis were observed in preliminary studies. Control animals were housed in the same room as the hypoxia chamber in room air (21% O 2 ).
Hypoxyprobe-1. To assess tissue hypoxia, pregnant dams were injected with 60 mg/kg Hypoxyprobe-1 (pimonidazole; Chemicon International, Temecula, CA) 3 h before the embryos were collected. Embryos were sectioned, and labeling was detected with a monoclonal antibody provided with the Hypoxyprobe-1 kit followed by a goat anti-mouse secondary antibody conjugated to Alexa 488 (Santa Cruz Biotechnology, Santa Cruz, CA). Tissue sections were analyzed by florescence microscopy.
Embryo Morphology. Embryonic and cardiac morphology was assessed by using a Stemi 2000-C dissecting microscope (Zeiss, Thornwood, NY). Digital images were captured for whole embryos with an Olympus (Center Valley, PA) DP 10 camera. Quantitative measurements of the C-R length and hearts were taken from printouts of the embryos and hearts. Embryos were fixed, embedded in paraffin, and sectioned as described previously (42) . Sections were stained with Harris-modified hematoxylin/eosin Y according to standard procedures (Fisher Scientific, Fair Lawn, NJ). Images were analyzed for cross-sectional area of various cardiac structures by using Image-Pro Plus (Media Cybernetics, Silver Spring, MD) analysis software. All area analysis was taken from sagittal sections of embryos at the level of the junction of the AV canal and the ventricle. The area of the ventricular myocardium, AV canal cushions or outflow tract (OFT) cushions were outlined, and the area was determined by the imaging software. Every third section was analyzed, and five or six sections per embryo were quantitated. The average area for each cardiac structure was determined for each embryo. On the younger embryos, the number of transformed mesenchyme in the AV canal cushions was determined from the same sections used for area analysis. Quantitation of cell transformation in the cushion was determined by dividing the number of cells by the cushion area (mesenchymal cells divided by 100 m 2 ).
TUNEL and Cell Proliferation Analysis. Apoptosis was assessed with the in situ cell death detection kit (Roche, Mannheim, Germany) according to the manufacturer's instructions as described previously (42) (43) (44) . Cell proliferation in cardiac tissue was determined by using an anti-phosphohistone H3 (Ser-10) antibody (Upstate Biotechnology, Lake Placid, NY). Embryos were fixed and sectioned as described above. After primary antibody, sections were incu- bated with the secondary antibody, goat anti-rabbit Alexa 488 (Molecular Probes, Eugene, OR) and counterstained with propidium iodide. Between 2,000 and 3,500 cells were counted in the ventricular myocardium of each embryo to determine the rate of cell proliferation. The cell proliferation rate is equal to H3-positive cells divided by the total number of cells (propidium iodide-positive).
Western Blot Analysis. Whole embryos were homogenized in lysis buffer (45) . Protein (40 g per lane) was separated on a 7.5% polyacrylamide HCl gel (Bio-Rad, Hercules, CA) followed by transfer to a nitrocellulose membrane. Blots were probed with antisera to HIF1␣ (Cayman Chemical, Ann Arbor, MI) and against GAPDH (Ambion, Austin, TX), as a control for sample loading. After detection, films were scanned into the computer, and band intensity was analyzed with the UN-SCAN-IT software (Silk Scientific, Orem, UT).
Real-Time PCRs. Total RNA was collected from whole embryos or isolated hearts at E10.5 with the RNeasy kit (Qiagen), and cDNA was prepared as described previously (42) . All real-time PCRs contained DyNAmo HS SYBR Green 2X Master Mix (Finnzymes, distributed by New England Biolabs, Beverly, MA) with 50 ng of cDNA and 0.5 M each primer, and they were performed at 55°C for 35 cycles with the Opticon 2 DNA Engine (Bio-Rad). All PCR primers were designed against mouse sequences including GAPDH (42) , all other real-time primers were obtained from SuperArray (Bioscience Corp., Frederick, MD). No DNA contamination was detected in any of the PCRs (data not shown). Real-time PCR was performed in triplicate and normalized to GAPDH by the ⌬⌬C t method.
PCR Focused-Array Studies. One reverse transcription reaction, containing 1 g of RNA, was used for each 96-well PCR array. The hypoxia signaling pathway PCR Array (SuperArray) was used to analyze gene expression in isolated hearts (46) . Each focused array contained five housekeeping genes to control for template concentration. PCR arrays were performed and analyzed as described above for real-time PCR.
Whole-Embryo Cultures. A 1 ARϩ/ϩ mice were used for wholeembryo cultures that were performed as described (42, 43, 47) . Control embryos were exposed to 5% O 2 (balance N 2 ) from 0 to 24 h, followed by 20% O 2 from 24 to 48 h (47) . To induce hypoxia, embryos were exposed to 5% O 2 from 0 to 36 h followed by 20% O 2 from 36 to 48 h.
Statistical Analysis. The data are presented as mean Ϯ SEM. Analyses were performed by using the statistics software package included with Excel (Microsoft, Redmond, WA) and GraphPad Prism (GraphPad Software, San Diego, CA). Statistical comparisons between groups were performed with Student's t tests (two-sample assuming equal variances) and two-way ANOVA. A P Ͻ 0.05 was considered to indicate statistical significance.
